These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 10343053)

  • 21. Wyeth Pharmaceutical's perspective on vaccine production.
    Stiles GL
    Md Med; 2005; 6(1):22-3. PubMed ID: 15869103
    [No Abstract]   [Full Text] [Related]  

  • 22. Package inserts, adverse drug reactions, and the physician's liability.
    Morrell MX
    Ration Drug Ther; 1975 Aug; 9(8):1-6. PubMed ID: 1144773
    [No Abstract]   [Full Text] [Related]  

  • 23. Members of new FDA board tied to industry.
    Finkelstein JB
    J Natl Cancer Inst; 2008 Mar; 100(5):296-7. PubMed ID: 18314467
    [No Abstract]   [Full Text] [Related]  

  • 24. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
    Ochs A
    Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
    [No Abstract]   [Full Text] [Related]  

  • 25. Vioxx, radiology, and the Food and Drug Administration.
    Pentecost MJ
    J Am Coll Radiol; 2005 May; 2(5):394-7. PubMed ID: 17411841
    [No Abstract]   [Full Text] [Related]  

  • 26. Implications of the Lannett and Pharmadyne decisions.
    Vetrano AJ
    Am J Hosp Pharm; 1980 Apr; 37(4):537-40. PubMed ID: 7377217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RU 486 and the politics of drug regulation in the United States and France.
    Kramnick RK
    Cornell Int Law J; 1992; 25():667-718. PubMed ID: 11656340
    [No Abstract]   [Full Text] [Related]  

  • 28. Genomic torts: a response to Professor Feldman.
    Rich WJ
    Washburn Law J; 2003; 42(3):615-21. PubMed ID: 15115003
    [No Abstract]   [Full Text] [Related]  

  • 29. Reuser friendly: a review of the regulation of and the product liability regarding the reuse of single-use medical devices.
    Wood JM; Heyman GF
    Tort Insur Law J; 2001; 37(1):41-78. PubMed ID: 11963939
    [No Abstract]   [Full Text] [Related]  

  • 30. Abbott Laboratories Consent Decree and individual responsibility under the Federal Food, Drug, and Cosmetic Act.
    Blumberg EM
    Food Drug Law J; 2000; 55(1):145-9. PubMed ID: 12322721
    [No Abstract]   [Full Text] [Related]  

  • 31. Litigation plays protective role--and is part of the problem.
    Kennett JD
    Mo Med; 2007; 104(1):12-3. PubMed ID: 17410818
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 33. Trends and events in FDA regulation of medical devices over the last fifty years.
    Munsey RR
    Food Drug Law J; 1995; 50 Spec():163-77. PubMed ID: 10343041
    [No Abstract]   [Full Text] [Related]  

  • 34. Fifty years of cosmetic safety: a government and industry partnership.
    Donegan TJ
    Food Drug Law J; 1995; 50 Spec():151-62. PubMed ID: 10343040
    [No Abstract]   [Full Text] [Related]  

  • 35. The doctor, the pharmacist, the patient, and the placebo, or you're not my mother, doctor.
    Nielsen JR
    Food Drug Cosmet Law J; 1989 Nov; 44(6):639-57. PubMed ID: 11659226
    [No Abstract]   [Full Text] [Related]  

  • 36. Pediatric Research Equity Act.
    J Natl Cancer Inst; 2004 Dec; 96(24):1810. PubMed ID: 15601636
    [No Abstract]   [Full Text] [Related]  

  • 37. Express preemption and premarket approval under the Medical Device Amendments.
    Scandaglia GJ; Tully TL
    Food Drug Law J; 2004; 59(2):245-64. PubMed ID: 15318395
    [No Abstract]   [Full Text] [Related]  

  • 38. Daubert v. Merrell Dow: missed opportunity.
    Jackson KA
    Food Drug Law J; 1995; 50(1):71-93. PubMed ID: 10342987
    [No Abstract]   [Full Text] [Related]  

  • 39. Revisiting Factor VIII cases: is it time for an agency adjudication system?
    Su YC
    Food Drug Law J; 2008; 63(4):943-61. PubMed ID: 19601390
    [No Abstract]   [Full Text] [Related]  

  • 40. The judicial coordination of drug and device litigation: a review and critique.
    Wood JM
    Food Drug Law J; 1999; 54(3):325-61. PubMed ID: 11797702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.